Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
29.83
-0.24 (-0.80%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Spotlight on Pfizer: Analyzing the Surge in Options Activity
June 10, 2024
Via
Benzinga
Masters In Trading - Saturday, June 8
June 08, 2024
In this video, I review the most recent trading session. I also discuss what a trader's
Via
Talk Markets
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
June 08, 2024
These stocks offer great dividends and more.
Via
The Motley Fool
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
June 07, 2024
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.
Via
Benzinga
Exposures
COVID-19
Product Safety
2 Dividend Stocks Billionaires Are Buying: Should You?
June 07, 2024
That's not a bad crowd to follow when investing in stocks.
Via
The Motley Fool
Check Out What Whales Are Doing With PFE
June 06, 2024
Via
Benzinga
Pfizer Unusual Options Activity For June 03
June 03, 2024
Via
Benzinga
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
June 06, 2024
Novavax will be ready for the new Covid-19 JN.1 variants in September, but NVAX stock is also undergoing a short squeeze.
Via
InvestorPlace
Exposures
COVID-19
Novavax, With A 369% Gain, Tears Ahead Again On Key FDA Move
June 06, 2024
Novavax also said it's planning to launch a JN.1-focused Covid booster shot this fall.
Via
Investor's Business Daily
Exposures
COVID-19
Product Safety
Why Is Novavax (NVAX) Stock Up 20% Today?
June 05, 2024
Novavax continues to march higher in its recovery efforts, with its latest vaccine announcement lifting NVAX stock.
Via
InvestorPlace
What's Going On With Novavax Stock?
June 05, 2024
Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at what's going on.
Via
Benzinga
2 High-Yield Dividend Stocks to Buy Right Now
June 05, 2024
These two high-yield dividend stocks are top buys right now.
Via
The Motley Fool
Alphabet, Ventas, ASML And A Pharmaceutical Giant On CNBC's 'Final Trades'
June 05, 2024
Alphabet recently declared a $2 billion investment plan to establish its inaugural data center and Google Cloud region in Malaysia.
Via
Benzinga
Why Things Could Get Worse for Pfizer Stock Before They Get Better
June 05, 2024
Investors shouldn't expect a big improvement in Pfizer's financials this year.
Via
The Motley Fool
7 Dividend Stocks to Invest In for a Lifetime of Income
June 05, 2024
Discover top dividend stocks to buy for 2024 to maximize profits and minimize risks in today’s investing environment.
Via
InvestorPlace
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
June 04, 2024
On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co...
Via
Benzinga
The Income Investor’s Dream Team: 7 Sturdy Dividend Stocks Yielding 6%
June 04, 2024
Dividend stocks yielding 6% are at the higher end of risk but these shares won't fail income investors anytime soon.
Via
InvestorPlace
7 High-Yield Dividend Stocks That Work While You Sleep
June 04, 2024
Although it’s easy to focus only on compelling growth plays, investors should also branch out to high-yield dividend stocks.
Via
InvestorPlace
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
June 04, 2024
Pfizer's list of patent-protected medicines is growing by leaps and bounds, but its stock price is under pressure.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Large Cap BIopharmaceuticals Overview
June 03, 2024
As a defensive play healthcare is weighted at about 12% of the S&P 500.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
June 03, 2024
This pair of high-yield dividend payers offer yields near 6% and a chance for steady payout raises in the years to come.
Via
The Motley Fool
Is Moderna Stock a Buy Now That It's a 2-Product Company?
June 03, 2024
The Food and Drug Administration recently approved a new vaccine from Moderna, but the stock dipped in response.
Via
The Motley Fool
7 Overlooked Stocks That Belong in Every Portfolio
June 03, 2024
Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks.
Via
InvestorPlace
Moderna Investors Just Got Some Bullish News
June 03, 2024
This news could be worth billions...
Via
The Motley Fool
3 Discounted Stocks Poised for a Major Upswing
June 02, 2024
Explore discounted upswing stocks with strong financials and strategic advantages heading for a rebound soon.
Via
InvestorPlace
Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount
June 02, 2024
Sometimes top companies make bottom-shelf decisions; such is the case with these seven blue-chip stocks to sell.
Via
InvestorPlace
3 Stocks to Buy for Huge Income
June 01, 2024
All 3 of these stocks have a yield above 5%.
Via
The Motley Fool
Is Pfizer the Best Dividend Stock for You?
June 01, 2024
Short-term expectation worries have elevated Pfizer's dividend yield.
Via
The Motley Fool
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer
May 31, 2024
Pfizer's Phase 3 CROWN trial results show Lorbrena significantly outperforms Xalkori in treating ALK-positive advanced NSCLC.
Via
Benzinga
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31, 2024
Moderna's RSV vaccine will launch a year behind Pfizer and GSK, but it could become the market leader over the next five years.
Via
Investor's Business Daily
Exposures
Product Safety
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.